formato europeo per il curriculum vitae
Transcript
formato europeo per il curriculum vitae
INFORMAZIONI PERSONALI Nome Data di nascita Qualifica Incarico attuale Numero telefonico dell’ufficio Fax dell’ufficio E-mail istituzionale MATTEO PELOSINI 28 LUGLIO 78 MEDICO CHIRUGO, SPECIALISTA IN EMATOLGIA DIRIGENTE MEDICO, CENTRO AZIENDALE EMATOLOGIA 0586223416, 0586223284, 0586223458 0586223284 [email protected] TITOLI DI STUDIO E PROFESSIONALI ED ESPERIENZE LAVORATIVE Titolo di studio Altri titoli di studio e professionali Esperienze professionali (incarichi ricoperti Laurea Specialistica in Medicina e Chirurgia 2003 Specializzazione in Ematologia 2007 Dottore di Ricerca in Microbiologia e Genetica 2012 Medico in formazione c/o U.O. Ematologia Pisa periodo 2004-2007 Visiting physician c/o MD Anderson Cancer Center, Houston, TX, USA 2008 Attività medica c/o U.O. Ematologia Pisa nel campo delle patologie oncoloematologiche e dei trapianti Attività di assistenza domiciliare nei pazienti ematologici Dottorando di ricerca in microbiologia e genetica 2009-2012 Assunzione come dirigente medico ematologo c/ Centro Aziendale Ematologia, Livorno Capacità linguistiche • Capacità di lettura • Capacità di scrittura • Capacità di espressione orale • Capacità di uso delle tecnologie INGLESE BUONA BUONA BUONA COMPLETA AUTONOMIA NELL'USO DEI SUPPORTI INFERMATICI Altro (partecipazione a convegni e seminari, pubblicazioni, collaborazione a riviste, ecc., ed ogni altra informazione che il dirigente ritiene di dover pubblicare) ARTICOLI Pelosini, M., Benedetti, E.,Galimberti, S., Caracciolo, F., Petrini,M., Fazzi, R., Andreazzoli, F., Papineschi, F., Granulocytic sarcoma and subsequent acute leukemia recurrenee with different biologic characteristic 5 years after Allogeneic bone marrow transplantation for acute myeloid leukemia. Bone Marrow Transplantation, , num. 9, vol. 37, pp. 897-898, 2006 Pelosini M, Galimberti S, Benedetti E, Caracciolo F, Fazzi R, Petrini M, Papineschi F. Skin and stomach graft versus host disease after syngeneic BMT in CML: A case report. Leuk Res. 2007 Feb 26; Cervetti G, Carulli G, Galimberti S, Azzara A, Buda G, Orciuolo E, Pelosini M, Petrini M. Transitory marrow aplasia during Imatinib therapy in a patient with chronic myeloid leukemia. Leuk Res. 2007 Apr 23 Galimberti S, Palumbo GA, Caracciolo F, Benedetti E, Pelosini M, Brizzi S, Ciabatti E, Fazzi R, Stelitano C, Quintana G, Conte E, Tibullo D, Di Raimondo F, Petrini M The efficacy of rituximab plus Hyper-CVAD regimen in mantle cell lymphoma is independent of FCgammaRIIIa and FCgammaRIIa polymorphisms. J Chemother. 2007 Jun;19(3):315-21. Pelosini M, Focosi D, Rita F, Galimberti S, Caracciolo F, Benedetti E, Papineschi F, Petrini M. Progressive multifocal leukoencephalopathy: report of three cases in HIV-negative hematological patients and review of literature. Ann Hematol. 2008 May;87(5):405-12. Epub 2007 Dec 7. Qazilbash MH, Saliba RM, Nieto Y, Parikh G, Pelosini M, Khan FB, Jones RB, Hosing C, Mendoza F, Weber DM, Wang M, Popat U, Alousi A, Anderlini P, Champlin RE, Giralt S. Arsenic trioxide with ascorbic acid and high-dose melphalan: results of a phase II randomized trial. Biol Blood Marrow Transplant. 2008 Dec;14(12):1401-7. Focosi D, Pelosini M, Palla P, Galimberti S, Caracciolo F, Benedetti E, Papineschi F, Petrini M. Hypercytokinemia-induced metabolic encephalopathy in a multiple myeloma patient on hemodialysis undergoing autologous stem cell transplantation: Clinical response after plasma exchange. Transpl Immunol. 2009 Jun 16. Pelosini M., Baronti F., Petrini M. “Application of a compiter science Analysis to a Non Hodgkin Lymphomas patients’dataset”. Computational intelligence and bioengineering. IOS Press. 2009, Vol 196 edited by Masulli F: Micheli A. Sperduti A. Orciuolo E, Buda G, Pelosini M, Petrini M. Fludarabine, Bortezomib, Myocet and rituximab chemotherapy in relapsed and refractory mantle cell lymphoma. Br J Haematol. 2010 Mar;148(5):810-2. Epub 2009 Nov 16. Efebera YA, Qureshi SR, Cole SM, Saliba R, Pelosini M, Patel RM, Koca E, Mendoza FL, Wang M, Shah J, Alousi A, Hosing C, Popat U, Kebriaei P, Anderlini P, Khouri IF, Champlin R, Giralt S, Qazilbash MH. Reduced-intensity allogeneic hematopoietic stem cell transplantation for relapsed multiple myeloma. Biol Blood Marrow Transplant. 2010 Aug;16(8):1122-9. Epub 2010 Feb 21. Buda G, Carulli G, Orciuolo E, Cannizzo E, Pelosini M, Galimberti S, Petrini M. CD23 expression in plasma cell leukaemia. Br J Haematol. 2010 Sep;150(6):724-5. Tuccori M, Focosi D, Blandizzi C, Pelosini M, Montagnani S, Maggi F, Pistello M, Antonioli L, Fornai M, Pepe P, Rossi G, Petrini M. Inclusion of rituximab in treatment protocols for nonHodgkin's lymphomas and risk for progressive multifocal leukoencephalopathy. Oncologist. 2010;15(11):1214-9. Galimberti S, Nagy B, Ciancia E, Caracciolo F, Benedetti E, Pelosini M, Focosi D, Petrini M. Outcome of patients with mantle cell lymphoma is not influenced by vascular endothelial growth factor polymorphisms.Leuk Lymphoma. 2011 Jan;52(1):142-4. Epub 2010 Nov 11. No abstract available. Buda G, Orciuolo E, Galimberti S, Pelosini M, Petrini M. Pegylated liposomal doxorubicin in combination with dexamethasone and bortezomib (VMD) or lenalidomide (RMD) in multiple myeloma pretreated patients. Ann Hematol. 2011 Sep;90(9):1115-6. Alatrash G, de Lima M, Hamerschlak N, Pelosini M, Wang X, Xiao L, Kerbauy F, Chiattone A, Rondon G, Qazilbash MH, Giralt SA, de Padua Silva L, Hosing C, Kebriaei P, Zhang W, Nieto Y, Saliba RM, Champlin RE, Andersson BSMyeloablative reduced-toxicity i.v. busulfan-fludarabine and allogeneic hematopoietic stem cell transplant for patients with acute myeloid leukemia or myelodysplastic syndrome in the sixth through eighth decades of life.. Biol Blood Marrow Transplant. 2011 Oct;17(10):1490-6. Epub 2011 Feb 18. Alatrash G, Pelosini M, Saliba RM, Koca E, Rondon G, Andersson BS, Chiattone A, Zhang W, Giralt SA, Cernosek AM, Kebriaei P, Alousi AM, Popat UR, Hosing C, Khouri IF, Champlin RE, de Lima MJ. Platelet recovery before allogeneic stem cell transplantation predicts posttransplantation outcomes in patients with acute myelogenous leukemia and myelodysplastic syndrome. Biol Blood Marrow Transplant. 2011 Dec;17(12):1841-5. Epub 2011 May 27. ABSTRACT E. Benedetti, F. Papineschi, F. Caracciolo, S. Galimberti, G. Cervetti, G. Castiglioni, S. Mechelli, P. Scatena, M. Pelosini, M. Petrini, In vivo purging with hyper-CVAD plus rituximab in newly diagnosed mantle cell lymphoma, Bone Marrow Transplantation, num. 33, SupplI, pp. 912-912, 2004 Benedetti, E., Caracciolo, F., Papineschi, F., Pelosini, M., Andreazzoli, D., Azzarà, A, Carulli, G.,Petrini, M., Gentuzimab omogozacin plus Flang in refractory/relapsed acute myeloid leukemias patients and pre-allogeneic stem cell transplant., Bone Marrow Transplantation, num. Supl.n°2,35, pp. 225-225, 2005 Benedetti, E., Caracciolo,F., Papineschi, F., Galimberti, S., Pelosini, M., Castiglioni,CM., Mechelli S., Scatena, Petrini,M., Hyper-CVAD and Rituximab as in vivo purging followed by autologous stem cell transplant and rituximab maintenance in newly diagnosed mantle cell lymphoma, Haematologica, num. Suppl.3, 90, pp. 420-420, 2005 Muzaffar H. Qazilbash, Rima M. Saliba, Matteo Pelosini, Chitra M Hosing, Floralyn L Mendoza, Eric Han, Michael Wang, Donna M. Weber, Amin M. Alousi, Paolo Anderlini, Partow Kebriaei, Issa F. Khouri, Uday R Popat, Marcos De Lima, Robert Z. Orlowski, Richard E. Champlin, and Sergio A. Giralt A Randomized Phase II Trial of High-Dose Melphalan, Ascorbic Acid and Arsenic Trioxide with or without Bortezomib in Multiple Myeloma Blood (ASH Annual Meeting Abstracts), Nov 2008; 112: 3320. Suzanne M. Cole, Rima Saliba, Matteo Pelosini, Floralyn L Mendoza, Donna Weber, Michael Wang, Sheeba Thomas, Robert Z. Orlowski, Jatin Shah, Amin Alousi, Chitra Hosing, Uday Popat, Partow Kebriaei, Paolo Anderlini, Issa F. Khouri, Richard Champlin, Sergio Giralt, and Muzaffar H. Qazilbash. Reduced-Intensity Regimens for Allogeneic Stem Cell Transplantation Improve the Outcome in Advanced Multiple Myeloma Blood (ASH Annual Meeting Abstracts), Nov 2008; 112: 3298 Gheath Alatrash, Matteo Pelosini, Rima M Saliba, Gabriela Rondon, Weiqing Zhang, Sergio Giralt, Partow Kebriaei, Amin Alousi, Issa F Khouri, Richard E Champlin, and Marcos De Lima Platelet Recovery Prior to Stem Cell Transplantation Predicts for Post- Transplant Outcomes in Patients with AML Blood (ASH Annual Meeting Abstracts), Nov 2008; 112: 3000. Gheath Alatrash, Borje S. Andersson, Matteo Pelosini, Gabrila Rondon, Muzaffar H. Qazilbash, Sergio Giralt, Leandro de Padua Silva, Chitra Hosing, Partow Kebriaei, Weiqing Zhang, Rima Saliba, Richard E. Champlin, and Marcos De Lima Myeloablative, Reduced Toxicity IV Busulfan/Fludarabine (BuFlu) and Allogeneic Hematopoietic Stem Cell Transplant (HSCT) for Patients in the 6th and 7th Decades of Life with AML or MDS Blood (ASH Annual Meeting Abstracts), Nov 2008; 112: 2999. M. Pelosini, F. Mendoza, C. Hosing, U.R. Popat, P. Anderlini, A.M. Alousi, P. Kebriaei, D.M. Weber, M. Wang, R.E. Champlin, S.A. Giralt, M.H. Qazilbash. Improved Outcome for Allogeneic Transplantation Performed After January 2000 Biology of Blood and Marrow Transplantation.February 2009 (Vol. 15, Issue 2, Pages 68-69) G. Alatrash, M. Pelosini, R. Saliba, G. Rondon, W. Zhang, S. Giralt, P. Kebriaei, Alousi, I. Khouri, R. Champlin, M. de Lima Post-Hematopoietic Stem Cell Transplantation (HSCT) Outcomes in Patients With AML Transplanted Prior to Achieving Platelet Recovery. Biology of Blood and Marrow Transplantation. February 2009 (Vol. 15, Issue 2, Page 58) G. Alatrash, B. Andersson, M. Pelosini, G. Rondon, M. Qazilbash, S. Giralt, L. de Padua Silva, C. Hosing, P. Kebriaei, W. Zhang, R. Saliba, R. Champlin, M. de Lima. Allogeneic Hematopoietic Stem Cell Transplant (HSCT) for Patients in the 6th and 7th Decades of Life with AML or MDS Using Myeloablative, Reduced Toxicity IV Busulfan/Fludarabine (BuFlu) Conditioning Regimen. Biology of Blood and Marrow Transplantation. February 2009 (Vol. 15, Issue 2, Page 106) Pelosini M. Baronti F. Galimberti S. Caracciolo F., Benedetti E., Papineschi F., Starita A., Petrini M. “Autologous stem cell transplantation improve outcome in NoHodgkin Lymphoma: results of a computer science analysis”. Bone marrow transplantation, Vol 43, supplement 1, March 2009 Benedetti E. Simonetti F. Caracciolo F. Papineschi F, Orsitto E., Tonerini M, Bruno B., Pelosini M., Focosi D., Petrini M. Neutropenic enterocolitis: usefulness of ulstrasoind sonography. Single centre experience” Bone marrow transplantation, Vol 43, supplement 1, March 2009 Benedetti E.. Caracciolo F. Papineschi F, Bruno B., McDonald G.B., Pelosini M., Focosi D., Ricchiuti A., Ceccarelli L., Petrini M. “Contrast enhanced ulstrasound sonography in intestinal acute graft versus host disease “.Bone marrow transplantation, Vol 43, supplement 1, March 2009